Table 1.
Various parameters from the blood samples of the COVID‐19, control, common COVID‐19, severe COVID‐19, and influenza groups
| COVID‐19 (N = 169) | Control (N = 80) | Common group (N = 145) | Severe group (N = 24) | Influenza (N = 131) | P a | P b | P c | P d | P e | |
|---|---|---|---|---|---|---|---|---|---|---|
| Age, y | 45.81 ± 14.84 | 46.0 ± 14.16 | 44.75 ± 14.69 | 52.21 ± 14.46 | 37.59 ± 21.19 | .934 | .022 | .000 | .001 | .000 |
| Male, N(%) | 87 (51.5) | 44 (55.0) | 70 (48.3) | 17 (70.8) | 60 (45.8) | .603 | .041 | .329 | .681 | .024 |
| WBC (×109/L) | 4.92 ± 1.75 | 6.43 ± 1.42 | 4.95 ± 1.80 | 4.72 ± 1.46 | 6.33 ± 2.35 | .000 | .543 | .000 | .000 | .000 |
| RBC (×1012/L) | 4.63 ± 0.50 | 4.60 ± 0.52 | 4.63 ± 0.51 | 4.62 ± 0.50 | 4.70 ± 0.65 | .689 | .918 | .265 | .288 | .537 |
| Hb, g/L | 135.44 ± 15.58 | 135.79 ± 15.07 | 135.27 ± 15.68 | 136.50 ± 15.24 | 136.69 ± 17.59 | .993 | .721 | .515 | .477 | .960 |
| PLT (×109/L) | 187.79 ± 63.93 | 256.88 ± 56.48 | 191.39 ± 63.46 | 166.04 ± 63.73 | 205.12 ± 69.96 | .000 | .072 | .026 | .088 | .012 |
| NE% | 64.50 ± 11.64 | 59.18 ± 9.24 | 63.26 ± 10.97 | 72.04 ± 12.94 | 68.42 ± 14.69 | .000 | .001 | .011 | .001 | .260 |
| LY% | 26.30 ± 10.52 | 31.20 ± 8.58 | 27.38 ± 10.07 | 19.75 ± 11.04 | 21.07 ± 12.85 | .000 | .001 | .000 | .000 | .638 |
| MO% | 7.60 (6.20‐9.95) | 7.20 (6.23‐8.48) | 7.70 (6.35‐10.00) | 6.70 (5.58‐9.55) | 9.0 (7.20‐11.40) | .059 | .224 | .000 | .000 | .007 |
| EO% | 0.60 (0.30‐1.15) | 1.50 (0.80‐2.18) | 0.60 (0.40‐1.20) | 0.30 (0.05‐0.50) | 0.40 (0.10‐1.10) | .000 | .000 | .038 | .000 | .163 |
| BA% | 0.20 (0.10‐0.30) | 0.40 (0.30‐0.70) | 0.20 (0.10‐0.30) | 0.10 (0.00‐0.20) | 0.10 (0.10‐0.30) | .000 | .000 | .001 | .000 | .118 |
| NE# (×109/L) | 2.93 (2.26‐3.79) | 3.63 (3.01‐4.50) | 2.89 (2.20‐3.79) | 3.03 (2.78‐4.02) | 4.26 (3.00‐5.74) | .000 | .229 | .000 | .000 | .018 |
| LY# (×109/L) | 1.12 (0.81‐1.54) | 1.92 (1.55‐2.29) | 1.17 (0.86‐1.63) | 0.73 (0.58‐1.01) | 1.08 (0.76‐1.54) | .000 | .000 | .364 | .074 | .012 |
| MO# (×109/L) | 0.36 (0.28‐0.48) | 0.45 (0.37‐0.55) | 0.36 (0.29‐0.48) | 0.33 (0.22‐0.49) | 0.55 (0.4‐0.71) | .000 | .299 | .000 | .000 | .000 |
| EO# (×109/L) | 0.03 (0.01‐0.05) | 0.10 (0.05‐0.14) | 0.03 (0.02‐0.06) | 0.01 (0.00‐0.02) | 0.02 (0.01‐0.06) | .000 | .000 | .418 | .107 | .021 |
| BA# (×109/L) | 0.01 (0.01‐0.01) | 0.03 (0.02‐0.04) | 0.01 (0.01‐0.02) | 0.01 (0.00‐0.01) | 0.01 (0.00‐0.01) | .000 | .000 | .359 | .047 | .002 |
Note: Data were expressed as mean (SD), medians (P25, P75), or N (%).
Abbreviations: BA#, basophil count; BA%, percentage of basophil; COVID‐19, coronavirus disease 2019; EO#, eosinophil count; EO%, percentage of eosinophil; Hb, haemoglobin; LY#, lymphocyte count; LY%, percentage of lymphocyte; MO#, monocyte count; MO%, percentage of monocytes; NE#, neutrophil count; NE%, percentage of neutrophils; PLT, platelet; RBC, red blood cell; WBC, white blood cell.
Comparison between COVID‐19 and control groups.
Comparison between common and severe groups.
Comparison between COVID‐19 and influenza groups.
Comparison between common and influenza groups.
Comparison between severe and influenza groups.